Distributes pharmaceuticals to healthcare providers and retailers.
Jun 2026Revenue $333B/yrExpenses $330B/yr
No trend
Figures by year
Is Cencora profitable?
Yes. In the 12 months to Jun 2026, revenue was $333B and expenses $330B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Sep 2025 | $321B | $319B | $2.63B |
| Sep 2024 | $294B | $292B | $2.18B |
| Sep 2023 | $262B | $260B | $2.34B |
| Sep 2022 | $239B | $236B | $2.37B |
| Sep 2021 | $214B | $212B | $2.35B |
| Sep 2020 | $190B | $195B | −$5.14B |
| Sep 2019 | $180B | $178B | $1.11B |
| Sep 2018 | $168B | $166B | $1.44B |
| Sep 2017 | $153B | $152B | $1.06B |
| Sep 2016 | $147B | $145B | $1.53B |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.